Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Medwave ; 15 Suppl 3: e6343, 2015 Dec 21.
Artículo en Inglés, Español | MEDLINE | ID: mdl-26731279

RESUMEN

Jet lag syndrome is an exogenous circadian rhythm sleep disorder, frequently reported in travelers who cross multiple time zones in a short period of time. Oral melatonin -a pineal neurohormone normally produced during darkness and responsible for regulating the body's circadian rhythms- has been used as treatment for this condition. Searching in Epistemonikos database, which is maintained by screening 30 databases, we identified four systematic reviews including 11 randomized trials. We combined the evidence using meta-analysis and generated a summary of findings table following the GRADE approach. We concluded the use of oral melatonin probably reduces symptoms associated with jet lag syndrome. It is not clear whether its use produces adverse effects; however, these would be probably mild.


El jet lag es un trastorno exógeno del sueño y el ritmo circadiano que ocurre frecuentemente en viajeros que cruzan múltiples zonas horarias en un tiempo reducido. La administración de melatonina oral, neurohormona epifisiaria relacionada con la regulación de ritmos circadianos, se ha utilizado con el fin de disminuir los síntomas que caracterizan esta condición. Utilizando la base de datos Epistemonikos, la cual es mantenida mediante búsquedas en 30 bases de datos, encontramos cuatro revisiones sistemáticas que en conjunto incluyen 11 estudios aleatorizados. Realizamos un metanálisis y tablas de resumen de los resultados utilizando el método GRADE. Concluimos que la administración de melatonina oral probablemente disminuye los síntomas asociados al jet lag, y que no está claro si se asocia a efectos adversos, aunque estos serían leves.


Asunto(s)
Antioxidantes/uso terapéutico , Síndrome Jet Lag/tratamiento farmacológico , Melatonina/uso terapéutico , Antioxidantes/administración & dosificación , Antioxidantes/efectos adversos , Ritmo Circadiano/fisiología , Humanos , Melatonina/administración & dosificación , Melatonina/efectos adversos , Ensayos Clínicos Controlados Aleatorios como Asunto , Viaje , Resultado del Tratamiento
2.
Neuro Endocrinol Lett ; 23 Suppl 1: 9-13, 2002 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-12019344

RESUMEN

In elderly insomniacs, melatonin treatment decreased sleep latency and increased sleep efficiency. This is particularly marked in Alzheimer's disease (AD) patients. Melatonin is effective to reduce significantly benzodiazepine use. In addition, melatonin administration synchronizes the sleep-wake cycle in blind people and in individuals suffering from delayed sleep phase syndrome or jet lag. Urinary levels of 6-sulphatoxymelatonin decrease with age and in chronic diseases like AD or coronary heart disease. The effect of melatonin on sleep is probably the consequence of increasing sleep propensity (by inducing a fall in body temperature) and of a synchronizing effect on the circadian clock (chronobiotic effect).


Asunto(s)
Síndrome Jet Lag/tratamiento farmacológico , Melatonina/uso terapéutico , Anciano , Animales , Humanos , Melatonina/farmacología , Sueño/efectos de los fármacos , Trastornos del Inicio y del Mantenimiento del Sueño/tratamiento farmacológico
3.
J Pineal Res ; 32(1): 41-6, 2002 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-11841599

RESUMEN

Rapid transmeridian translocation through multiple time zones has a negative impact on athletic performance. The aim of the present study was to test the timely use of three factors (melatonin treatment, exposure to light, physical exercise) to hasten the resynchronization of a group of elite sports competitors and their coaches to a westerly transmeridian flight comprising of 12 time-zones. Twenty-two male subjects were included in the study. They were professional soccer players and their coaches who travelled to Tokyo to play the final game of the Intercontinental Coup. The day prior to departure, urine was collected from each subject from 18:00 to 06:00 hrs to measure the melatonin metabolite 6-sulphatoxymelatonin. Participants were asked to complete sleep log diaries from day 0 (preflight) to the day before returning to Buenos Aires (day 8). All subjects received 3 mg of melatonin p.o. daily at expected bedtime at Tokyo immediately after leaving Buenos Aires. Upon arrival at Tokyo the subjects performed a daily physical exercise routine outdoors at two restricted times of the day (from 08:00 to 11:00 hrs in the morning and from 13:00 to 16:00 hrs in the afternoon). Exposure to sunlight or physical exercise at other times of the day was avoided. Except for the number of awakenings (which increased on days 1 and 3) and sleep latency (which decreased on days 2, 6 and 8), there was an absence of significant changes in subjective sleep parameters as compared with preflight assessment. Sleep quality and morning alertness at Tokyo correlated significantly with preflight 6-sulphatoxymelatonin excretion. Mean resynchronization rate of sleep-wake cycle to the 12 hr-time shift was 2.13 +/- 0.88 days, significantly different from the minimal resynchronization rate of 6 days expected after a 12-time-zones flight. The results indicate that the combination of melatonin treatment, an appropriate environmental light schedule and timely applied physical exercise can be useful to help elite athletes to overcome the consequences of jet lag.


Asunto(s)
Síndrome Jet Lag/tratamiento farmacológico , Melatonina/análogos & derivados , Melatonina/uso terapéutico , Adulto , Ejercicio Físico , Humanos , Síndrome Jet Lag/fisiopatología , Luz , Masculino , Melatonina/orina , Sueño , Fútbol , Deportes
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA